| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910792 | Lung Cancer | 2015 | 7 Pages |
Abstract
The LMR is an independent prognostic marker for OS in patients with MPM and is superior to other inflammation-based prognostic scores with respect to prognostic ability.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tomoko Yamagishi, Nobukazu Fujimoto, Hideyuki Nishi, Yosuke Miyamoto, Naofumi Hara, Michiko Asano, Yasuko Fuchimoto, Sae Wada, Kenichi Kitamura, Shinji Ozaki, Takumi Kishimoto,